Aspen concludes strategic MoU in Russia

South Africa’s Aspen Pharmacare (JSE: APN) has entered into a memorandum of understanding (MoU) has been concluded between Aspen’s Russian business and the Vladivostok Far Eastern Federal University (FEFU).

The Deputy Prime Minister of Russia Yury Trutnev, who has delegated authority from the Russian President for the Far Eastern Federal Region of Russia, oversaw proceedings and committed the region and university to this collaborative effort.

Stavros Nicolaou, Aspen senior executive strategic trade development, said: “The Group welcomes this latest collaboration with the Russian Federation which further complements existing relations with that country. The MoU provides for cooperative efforts to improve the quality of education and contribute towards advanced innovative technology in the fields of thrombosis and anesthesia through joint training and research efforts with the FEFU. The goal of the program is to decrease the mortality rate of thrombotic events and to increase the quality of anesthesia use in the Russian Federation. This will improve the life expectancy of Russian citizens in the medium to long term, as clinicians will have access to some of the newest low molecular weight heparin technology, which has an improved safety profile against older interventions.”